Related Experiment Video
Updated: Jul 25, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
Han Yang1,2, Yufang Liu1,2, Longqing Chen1,2
1Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, Zunyi Medical University, Zunyi 563000, China.
Abstract:
Lung cancer is a commonly diagnosed cancer and the leading cause of cancer-related deaths, posing a serious health risk. Despite new advances in immune checkpoint and targeted therapies in recent years, the prognosis for lung cancer patients, especially those in advanced stages, remains poor. MicroRNAs (miRNAs) have been shown to modulate tumor development at multiple levels, and as such, miRNA mimics and molecules aimed at regulating miRNAs have shown promise in preclinical development. More importantly, miRNA-based therapies can also complement conventional chemoradiotherapy, immunotherapy, and targeted therapies to reverse drug resistance and increase the sensitivity of lung cancer cells. Furthermore, small interfering RNA (siRNA) and miRNA-based therapies have entered clinical trials and have shown favorable development prospects. Therefore, in this paper, we review recent advances in miRNA-based therapies in lung cancer treatment as well as adjuvant therapy and present the current state of clinical lung cancer treatment. We also discuss the challenges facing miRNA-based therapies in the clinical application of lung cancer treatment to provide new ideas for the development of novel lung cancer therapies.
Insights
MicroRNAs (miRNAs) show promise in treating lung cancer, complementing existing therapies and reversing drug resistance. miRNA-based treatments are advancing into clinical trials for improved lung cancer patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Lung cancer is a leading cause of cancer deaths globally.
- Advanced lung cancer prognosis remains poor despite recent therapeutic advancements.
- MicroRNAs (miRNAs) play a crucial role in regulating tumor development.
Purpose of the Study:
- To review recent advances in microRNA (miRNA)-based therapies for lung cancer.
- To discuss the current state of clinical lung cancer treatment.
- To explore the potential of miRNA-based therapies as adjuvant treatments and to overcome drug resistance.
Main Methods:
- Review of current literature on miRNA-based therapies in lung cancer.
- Analysis of preclinical and clinical trial data for miRNA and small interfering RNA (siRNA) therapies.
- Discussion of challenges and future directions for miRNA-based lung cancer treatment.
Main Results:
- miRNA mimics and regulatory molecules show preclinical promise.
- miRNA-based therapies can enhance conventional treatments, reversing drug resistance.
- Small interfering RNA (siRNA) and miRNA therapies are progressing favorably in clinical trials.
Conclusions:
- miRNA-based therapies offer a promising avenue for lung cancer treatment and adjuvant therapy.
- These therapies have the potential to improve sensitivity and overcome resistance in lung cancer cells.
- Further research and clinical application are needed to address challenges and develop novel lung cancer therapies.
More Related Videos
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
MicroRNAs
Microorganisms in Medicine and Therapeutics
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...